KR940014313A - 하이드록시아미딘 유도체 - Google Patents

하이드록시아미딘 유도체 Download PDF

Info

Publication number
KR940014313A
KR940014313A KR1019930026826A KR930026826A KR940014313A KR 940014313 A KR940014313 A KR 940014313A KR 1019930026826 A KR1019930026826 A KR 1019930026826A KR 930026826 A KR930026826 A KR 930026826A KR 940014313 A KR940014313 A KR 940014313A
Authority
KR
South Korea
Prior art keywords
amino
alkyl
phenyl
compound
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019930026826A
Other languages
English (en)
Korean (ko)
Inventor
서홍숙
Original Assignee
베르너 발데그
시바-가이기 에이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베르너 발데그, 시바-가이기 에이지 filed Critical 베르너 발데그
Publication of KR940014313A publication Critical patent/KR940014313A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
KR1019930026826A 1992-12-09 1993-12-08 하이드록시아미딘 유도체 Withdrawn KR940014313A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7/987,856 1992-12-09
US07/987,856 US5455274A (en) 1992-12-09 1992-12-09 Hydroxyamidine derivatives

Publications (1)

Publication Number Publication Date
KR940014313A true KR940014313A (ko) 1994-07-18

Family

ID=25533631

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930026826A Withdrawn KR940014313A (ko) 1992-12-09 1993-12-08 하이드록시아미딘 유도체

Country Status (19)

Country Link
US (1) US5455274A (enExample)
EP (1) EP0601977B1 (enExample)
JP (1) JPH06263710A (enExample)
KR (1) KR940014313A (enExample)
AT (1) ATE148103T1 (enExample)
AU (1) AU671683B2 (enExample)
CA (1) CA2110838A1 (enExample)
DE (1) DE69307669T2 (enExample)
DK (1) DK0601977T3 (enExample)
ES (1) ES2096265T3 (enExample)
FI (1) FI935452A7 (enExample)
GR (1) GR3022367T3 (enExample)
HU (1) HUT65778A (enExample)
IL (1) IL107842A (enExample)
NO (2) NO934483D0 (enExample)
NZ (1) NZ250379A (enExample)
PH (1) PH29931A (enExample)
TW (2) TW267999B (enExample)
ZA (1) ZA939193B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504524A (ja) * 1993-10-21 1997-05-06 ジー.ディー.サール アンド カンパニー 酸化窒素シンターゼ阻害剤として有用なアミジノ誘導体
DE4424713A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe
JP2770769B2 (ja) * 1995-02-16 1998-07-02 日本メクトロン株式会社 ビスアミドキシム化合物、その製造法およびそれを含有する含フッ素エラストマー組成物
ID24720A (id) * 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
AU1616600A (en) * 1998-11-12 2000-05-29 Eli Lilly And Company Aminobenzisoxazole compounds and libraries thereof
US7262223B2 (en) 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
AU2005214167B2 (en) 2004-02-13 2008-08-07 Warner-Lambert Company Llc Androgen receptor modulators
CA2563291A1 (en) 2004-04-13 2005-10-27 Warner-Lambert Company Llc 4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
BRPI0509980A (pt) * 2004-04-22 2007-10-16 Warner Lambert Co moduladores de androgênio
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
US20080200526A1 (en) * 2004-07-05 2008-08-21 Jin Soo Lee Composition for the Prevention and Treatment of Allergic Inflammatory Disease
BRPI0513020A (pt) 2004-07-08 2008-04-22 Warner Lambert Co moduladores de andrÈgenio, seus usos, composição farmacêutica, formulação farmacêutica tópica e artigo de fabricação
KR20060017929A (ko) * 2004-08-04 2006-02-28 동화약품공업주식회사 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5922697B2 (ja) * 1976-01-13 1984-05-28 エーザイ株式会社 ビス−(メタ−アミジノフエノキシ)−化合物
NL7908922A (nl) * 1979-12-12 1981-07-16 Akzo Nv Carboximidamide derivaten.
US4324794A (en) * 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
US4717736A (en) * 1984-01-23 1988-01-05 Merck Frosst Canada, Inc. Antagonists of slow reacting substances of anaphylaxis
CA1243322A (en) * 1984-01-23 1988-10-18 Joshua Rokach Antagonists of slow reacting substances of anaphylaxis
DE3830054A1 (de) * 1988-09-03 1990-03-15 Boehringer Mannheim Gmbh Phenylamide - verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US4933347A (en) * 1988-10-25 1990-06-12 University Of North Carolina At Chapel Hill Diamidines and bis(imidazolines) for the treatment of and prophylaxis against pneumocystis carinii pneumonia
US4963589A (en) * 1988-10-25 1990-10-16 The University Of North Carolina At Chapel Hill Methods for treating Giardia lamblia
US5162361A (en) * 1990-04-10 1992-11-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Method of treating diseases associated with elevated levels of interleukin 1
US5124350A (en) * 1990-06-28 1992-06-23 G. D. Searle & Co. Leukotriene b4 antagonists
RU2124002C1 (ru) * 1992-02-05 1998-12-27 Берингер Ингельхейм КГ Производные амидина, смесь их изомеров или отдельные изомеры и их соли, фармацевтическая композиция, обладающая антагонистическим действием в отношении лейкотриена b4

Also Published As

Publication number Publication date
IL107842A0 (en) 1994-04-12
NO180300B (no) 1996-12-16
NZ250379A (en) 1995-12-21
EP0601977B1 (en) 1997-01-22
HUT65778A (en) 1994-07-28
NO934483D0 (no) 1993-12-08
AU671683B2 (en) 1996-09-05
DE69307669D1 (de) 1997-03-06
AU5218093A (en) 1994-06-23
ES2096265T3 (es) 1997-03-01
PH29931A (en) 1996-09-16
US5455274A (en) 1995-10-03
CA2110838A1 (en) 1994-06-10
GR3022367T3 (en) 1997-04-30
IL107842A (en) 1998-08-16
NO934483L (no) 1994-06-10
FI935452A7 (fi) 1994-06-10
DK0601977T3 (da) 1997-02-10
TW294651B (enExample) 1997-01-01
ZA939193B (en) 1994-06-09
FI935452A0 (fi) 1993-12-03
JPH06263710A (ja) 1994-09-20
ATE148103T1 (de) 1997-02-15
EP0601977A1 (en) 1994-06-15
DE69307669T2 (de) 1997-11-13
NO180300C (no) 1997-03-26
TW267999B (enExample) 1996-01-11
HU9303501D0 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
KR940014313A (ko) 하이드록시아미딘 유도체
KR940005555A (ko) 헤테로아세트산 유도체
CZ285896B6 (cs) Deriváty kyseliny hydroxamové, způsob jejich výroby, jejich použití pro výrobu farmaceutických prostředků a farmaceutické prostředky s jejich obsahem
NL300396I1 (nl) Nieuwe derivaten met naftalinestructuren, werkwijze voor de bereiding ervan en de farmaceutische preparaten die deze bevatten
RU2004134604A (ru) Тетрагидропиранилциклопентилтерагидропиридопиридиновые модуляторы активности рецептора хемокина
EA017806B1 (ru) Антимикробные соединения, их синтез и применение для лечения инфекций у млекопитающих
RU2012153164A (ru) Производные мочевины и их терапевтическое применение при лечении, среди прочего, заболеваний дыхательного пути
KR960041168A (ko) 베타-아드레날린 효능성 작용물질
RU2002135312A (ru) Средство, усиливающие секрецию гормона роста
JPS59130215A (ja) 錐体外運動障害の軽減法
EP0392802A3 (en) Preparation of urea analogues and their use in bronchial, cerebrovascular and neuronal disorders
RU2457201C2 (ru) (2r)-2-[(4-сульфонил)аминофенил]пропанамиды и содержащие их фармацевтические композиции
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
JP2008528634A (ja) 腫瘍壊死因子インヒビター
JP7229482B2 (ja) 新規アミド系化合物、並びにそれを用いたPin1阻害剤、炎症性疾患の治療剤及び癌の治療剤
CA2416535A1 (en) Non-sedating barbiturate compounds as neuroprotective agents
RU2004103079A (ru) Новые иммуномодулирующие соединения
KR930007914A (ko) 제1위치에 에테르 또는 티오에테르 그룹을 함유하는 프탈라진 및 이의 제조방법
KR910000734A (ko) 네플라노신 유도체
HU193530B (en) Process for preparing 9-/3-0-monosubstituted or 1,3-di-0-substituted propoxymethyl/-guanine derivatives and pharmaceutical compositions comprising such active substances
JP5484065B2 (ja) メラノコルチン受容体リガンドとしての新規アミノグアニジン
IE840132L (en) Benzoylurea compounds.
JP2002533336A5 (enExample)
DK149058C (da) Analogifremgangsmaade til fremstilling af 4-(4,4-(diphenyl)butyl)-1-acylpiperaziner eller syreadditionssalte deraf
US4713390A (en) Sulfurated hydantoin derivatives and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19931208

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 19970731

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid